Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cell Adhesion Molecules - Types and Functions01:20

Cell Adhesion Molecules - Types and Functions

6.8K
Cell adhesion molecules (CAMs) are pivotal to multicellularity and the coordinated functioning of tissues and organ systems. They enable physical interactions between cells and provide mechanical strength to tissues. They also function as receptors for signal transmission across the plasma membrane. The CAMs are broadly classified into four families - integrins, cadherins, selectins, and immunoglobulin-like CAMs (IgCAMs).
CAM Families
The Integrin family of proteins is primarily  involved...
6.8K
Metastasis02:30

Metastasis

5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

miR-1-3p downregulation drives tumor invasion in oral squamous cell carcinoma: insights from in vitro, in vivo, and ex vivo models.

Molecular biology reports·2026
Same author

Zebrafish as a Model for Translational Immuno-Oncology.

Journal of personalized medicine·2025
Same author

Chemotherapy-induced neuropathy in monomethyl Auristatin E treatment: prevention by lithium.

British journal of cancer·2025
Same author

SLIT/ROBO Pathway and Prostate Cancer: Gene and Protein Expression and Their Prognostic Values.

International journal of molecular sciences·2025
Same author

Telocytes: current methods of research, challenges and future perspectives.

Cell and tissue research·2024
Same author

Automated, High-Throughput Screening of Hybrid Elastin-like Polypeptide/Polysaccharide Multilayer Film Deposition.

Biomacromolecules·2023

Related Experiment Video

Updated: Jul 15, 2025

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells
05:58

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells

Published on: October 13, 2023

1.3K

Circulating Tumor Cells Adhesion: Application in Biosensors.

Eduarda B Paglia1, Estela K K Baldin1,2, Gabriela P Freitas1,2

  • 1School of Chemical Engineering, Department of Process and Product Development, University of Campinas, Campinas 13083-852, Brazil.

Biosensors
|September 27, 2023
PubMed
Summary
This summary is machine-generated.

Early cancer diagnosis relies on detecting circulating tumor cells (CTCs). This review explores novel electrochemical biosensors using specific biomarkers like CD44 for improved CTC capture and non-invasive cancer diagnosis.

Keywords:
CD44EpCAmcirculating tumor cellselectrochemical biosensorintegrins

More Related Videos

Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications
14:14

Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications

Published on: February 28, 2014

15.9K
Capture and Release of Viable Circulating Tumor Cells from Blood
08:10

Capture and Release of Viable Circulating Tumor Cells from Blood

Published on: October 28, 2016

8.5K

Related Experiment Videos

Last Updated: Jul 15, 2025

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells
05:58

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells

Published on: October 13, 2023

1.3K
Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications
14:14

Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications

Published on: February 28, 2014

15.9K
Capture and Release of Viable Circulating Tumor Cells from Blood
08:10

Capture and Release of Viable Circulating Tumor Cells from Blood

Published on: October 28, 2016

8.5K

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Analytical Chemistry

Background:

  • Early and non-invasive diagnosis of tumor diseases is crucial.
  • Detecting circulating tumor cells (CTCs) is a key focus.
  • Current CTC capture and enrichment strategies need enhanced selectivity.

Purpose of the Study:

  • To review novel approaches for CTC capture and enrichment.
  • To explore the application of specific biomarkers in electrochemical biosensors.
  • To improve the sensitivity and specificity of cytosensors for cancer diagnosis.

Main Methods:

  • Investigating biological recognition factors for cancer cell lines.
  • Analyzing surface parameter interactions with macromolecule-cell surface affinity.
  • Utilizing electrochemical sensors as transduction platforms.
  • Exploring various materials, geometries, and technologies for electrode enhancement.

Main Results:

  • Identified novel approaches for CTC capture using specific biomarkers.
  • Highlighted the potential of CD44, Integrins, and EpCAM as capture agents.
  • Demonstrated the efficacy of electrochemical biosensors for precise and rapid detection.
  • Emphasized the role of electrode properties in improving sensitivity and specificity.

Conclusions:

  • Electrochemical biosensors offer a promising platform for CTC detection.
  • Specific biomarkers significantly enhance the selectivity of CTC capture.
  • These advancements contribute to improved non-invasive diagnostic strategies for cancerous diseases.